NEO
NeoGenomics, Inc. NASDAQ Listed Mar 16, 2004$11.13
+7.23%
vs $10.38
Mkt Cap $285.2M
52w Low $4.84
75.1% of range
52w High $13.22
50d MA $9.32
200d MA $10.00
P/E (TTM)
-2.6x
EV/EBITDA
303.8x
P/B
0.3x
Debt/Equity
0.6x
ROE
-12.0%
P/FCF
-13.1x
RSI (14)
56.40
ATR (14)
$0.63
Beta
1.71
50d MA
$9.32
200d MA
$10.00
Avg Volume
2.1M
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
9490 NeoGenomics Way · Fort Myers, FL 33912 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | AMC | 0.01 | 0.01 | +72.7% | 9.02 | +13.6% | -0.7% | +3.3% | +1.9% | -4.7% | -2.3% | — |
| Feb 17, 2026 | AMC | 0.04 | 0.06 | +50.0% | 11.44 | -0.3% | -10.3% | -2.4% | -1.2% | +0.8% | -3.2% | — |
| Oct 28, 2025 | AMC | 0.02 | 0.03 | +50.0% | 9.92 | +1.9% | +3.6% | -5.7% | +0.8% | +0.1% | +3.3% | — |
| Jul 29, 2025 | AMC | 0.03 | 0.03 | +0.0% | 5.25 | -0.6% | -2.9% | -5.1% | +6.6% | +9.9% | -0.9% | — |
| Apr 29, 2025 | AMC | -0.02 | -0.08 | -300.0% | 6.58 | -1.7% | -2.7% | +13.4% | +6.1% | +1.8% | -1.9% | — |
| Feb 18, 2025 | AMC | 0.03 | 0.04 | +33.3% | 12.41 | -1.6% | +2.5% | -6.8% | -6.4% | +0.6% | -2.6% | — |
| Nov 5, 2024 | AMC | 0.01 | 0.05 | +316.7% | 14.93 | +5.0% | +3.5% | +2.3% | -0.3% | +3.7% | -0.1% | — |
| Jul 29, 2024 | AMC | 0.00 | 0.03 | +879.1% | 14.64 | +8.5% | +18.0% | +2.7% | -1.3% | -1.9% | -5.6% | — |
| Apr 30, 2024 | AMC | -0.01 | -0.02 | -58.9% | 13.92 | +0.6% | +0.3% | +5.4% | +3.9% | +1.4% | +0.4% | — |
| Feb 20, 2024 | AMC | 0.01 | 0.03 | +220.1% | 14.70 | +11.6% | +12.1% | -0.2% | +2.1% | -3.1% | -0.9% | — |
| Nov 6, 2023 | AMC | -0.07 | -0.06 | +14.3% | 14.65 | +9.2% | +14.2% | -5.4% | -0.7% | +0.3% | +2.0% | — |
| Aug 8, 2023 | AMC | -0.10 | -0.05 | +50.0% | 15.32 | -0.2% | -3.3% | -4.8% | -0.3% | -0.9% | -3.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Leerink Partners | Upgrade | Market Perform → Outperform | $25 | $9.02 | $10.25 | +13.6% | -0.7% | +3.3% | +1.9% | -4.7% | -1.6% |
| Apr 29 | TD Cowen | Maintains | Buy → Buy | — | $9.02 | $10.25 | +13.6% | -0.7% | +3.3% | +1.9% | -4.7% | -1.6% |
| Apr 29 | Benchmark | Upgrade | Hold → Buy | — | $9.02 | $10.25 | +13.6% | -0.7% | +3.3% | +1.9% | -4.7% | -1.6% |
| Feb 24 | Piper Sandler | Maintains | Overweight → Overweight | — | $9.97 | $10.18 | +2.1% | -3.2% | +1.8% | +3.6% | -3.3% | -3.4% |
| Feb 17 | Needham | Maintains | Buy → Buy | — | $11.38 | $10.50 | -7.7% | +0.5% | -10.3% | -2.4% | -1.2% | +0.8% |
| Jan 12 | Needham | Maintains | Buy → Buy | — | $13.16 | $13.26 | +0.8% | -5.1% | +3.5% | +2.2% | -3.0% | -0.3% |
| Sep 12 | TD Cowen | Maintains | Buy → Buy | — | $8.34 | $8.38 | +0.5% | -4.6% | +1.5% | -1.1% | +1.5% | +6.3% |
| Sep 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $8.78 | $8.76 | -0.2% | +0.3% | -7.0% | -1.6% | -1.0% | -0.6% |
| Aug 29 | Needham | Maintains | Buy → Buy | — | $7.21 | $8.78 | +21.8% | +21.8% | +0.3% | -7.0% | -1.6% | -1.0% |
| Aug 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.16 | $5.21 | +1.0% | +9.9% | -0.9% | -2.3% | +4.9% | +0.7% |
| Jul 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $5.25 | $5.22 | -0.6% | -2.9% | -5.1% | +6.6% | +9.9% | -0.9% |
| Jul 29 | William Blair | Downgrade | Outperform → Market Perform | — | $6.46 | $5.30 | -18.0% | -18.7% | -2.9% | -5.1% | +6.6% | +9.9% |
| Jul 29 | Needham | Maintains | Buy → Buy | — | $6.46 | $5.30 | -18.0% | -18.7% | -2.9% | -5.1% | +6.6% | +9.9% |
| May 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $7.84 | $7.83 | -0.1% | -1.9% | +4.0% | +1.6% | -1.0% | +5.7% |
| May 1 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $6.40 | $6.47 | +1.1% | +13.4% | +6.1% | +1.8% | -1.9% | +4.0% |
| Apr 30 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $6.58 | $6.47 | -1.7% | -2.7% | +13.4% | +6.1% | +1.8% | -1.9% |
| Apr 30 | Goldman Sachs | Maintains | Buy → Buy | — | $6.58 | $6.47 | -1.7% | -2.7% | +13.4% | +6.1% | +1.8% | -1.9% |
| Apr 29 | Needham | Maintains | Buy → Buy | — | $9.97 | $9.64 | -3.3% | -34.0% | -2.7% | +13.4% | +6.1% | +1.8% |
| Apr 17 | Goldman Sachs | Maintains | Buy → Buy | — | $9.56 | $9.50 | -0.6% | -0.1% | +0.3% | +1.8% | +1.6% | +1.8% |
| Feb 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.88 | $10.87 | -0.1% | -4.4% | -5.6% | +1.7% | -4.1% | -2.5% |
| Feb 19 | BofA Securities | Maintains | Neutral → Neutral | — | $12.41 | $12.21 | -1.6% | +2.5% | -6.8% | -6.4% | +0.6% | -2.6% |
| Feb 19 | Needham | Maintains | Buy → Buy | — | $12.41 | $12.21 | -1.6% | +2.5% | -6.8% | -6.4% | +0.6% | -2.6% |
| Jan 28 | Goldman Sachs | Maintains | Buy → Buy | — | $15.04 | $15.02 | -0.1% | +0.9% | -4.0% | +1.6% | -3.4% | -2.9% |
| Jan 16 | Benchmark | Maintains | Hold → Hold | — | $14.71 | $14.63 | -0.5% | -5.0% | +1.6% | -0.2% | +2.3% | +1.1% |
| Jan 15 | Needham | Maintains | Buy → Buy | — | $13.78 | $14.95 | +8.5% | +6.7% | -5.0% | +1.6% | -0.2% | +2.3% |
| Jan 13 | Benchmark | Downgrade | Buy → Hold | — | $14.77 | $14.11 | -4.5% | -14.5% | +9.1% | +6.7% | -5.0% | +1.6% |
| Jan 10 | Needham | Maintains | Buy → Buy | — | $18.61 | $17.75 | -4.6% | -20.6% | -14.5% | +9.1% | +6.7% | -5.0% |
| Dec 13 | BofA Securities | Maintains | Neutral → Neutral | — | $17.90 | $17.72 | -1.0% | -0.9% | +1.4% | -2.3% | -6.0% | -0.5% |
| Nov 6 | Needham | Maintains | Buy → Buy | — | $14.93 | $15.68 | +5.0% | +3.5% | +2.3% | -0.3% | +3.7% | -0.1% |
| Sep 25 | Needham | Maintains | Buy → Buy | — | $15.80 | $15.78 | -0.1% | -5.3% | -2.1% | -1.0% | +1.7% | -6.4% |
| Sep 24 | Benchmark | Maintains | Buy → Buy | — | $15.80 | $15.94 | +0.9% | +0.0% | -5.3% | -2.1% | -1.0% | +1.7% |
| Jul 30 | Benchmark | Maintains | Buy → Buy | — | $14.64 | $15.89 | +8.5% | +18.0% | +2.7% | -1.3% | -1.9% | -5.6% |
| Jul 30 | Needham | Maintains | Buy → Buy | — | $14.64 | $15.89 | +8.5% | +18.0% | +2.7% | -1.3% | -1.9% | -5.6% |
| Jul 30 | Stephens & Co. | Maintains | Overweight → Overweight | — | $14.64 | $15.89 | +8.5% | +18.0% | +2.7% | -1.3% | -1.9% | -5.6% |
| May 2 | BTIG | Maintains | Buy → Buy | — | $13.96 | $14.03 | +0.5% | +5.4% | +3.9% | +1.4% | +0.4% | -2.8% |
| May 1 | Benchmark | Maintains | Buy → Buy | — | $13.92 | $14.00 | +0.6% | +0.3% | +5.4% | +3.9% | +1.4% | +0.4% |
| May 1 | TD Cowen | Maintains | Buy → Buy | — | $13.92 | $14.00 | +0.6% | +0.3% | +5.4% | +3.9% | +1.4% | +0.4% |
| Apr 30 | Needham | Maintains | Buy → Buy | — | $15.22 | $14.92 | -2.0% | -8.5% | +0.3% | +5.4% | +3.9% | +1.4% |
| Feb 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $16.79 | $16.87 | +0.5% | -3.1% | -0.9% | -3.5% | +0.3% | +2.4% |
| Feb 22 | Goldman Sachs | Maintains | Buy → Buy | — | $16.48 | $16.69 | +1.3% | -0.2% | +2.1% | -3.1% | -0.9% | -3.5% |
| Feb 21 | Needham | Maintains | Buy → Buy | — | $14.70 | $16.40 | +11.6% | +12.1% | -0.2% | +2.1% | -3.1% | -0.9% |
| Dec 29 | BTIG | Maintains | Buy → Buy | — | $16.79 | $16.82 | +0.2% | -3.6% | -1.4% | +1.0% | -2.1% | -1.0% |
| Dec 29 | TD Cowen | Maintains | Outperform → Outperform | — | $16.79 | $16.82 | +0.2% | -3.6% | -1.4% | +1.0% | -2.1% | -1.0% |
| Dec 28 | Needham | Maintains | Buy → Buy | — | $20.50 | $18.05 | -12.0% | -18.1% | -3.6% | -1.4% | +1.0% | -2.1% |
| Nov 8 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $16.73 | $16.80 | +0.4% | -5.4% | -0.7% | +0.3% | +2.0% | +8.7% |
| Nov 7 | Needham | Maintains | Buy → Buy | — | $14.65 | $16.00 | +9.2% | +14.2% | -5.4% | -0.7% | +0.3% | +2.0% |
| Oct 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $13.71 | $13.76 | +0.4% | +7.6% | -1.2% | -0.4% | -6.2% | +0.0% |
| Oct 23 | Goldman Sachs | Maintains | Buy → Buy | — | $13.90 | $13.60 | -2.2% | -1.4% | +7.6% | -1.2% | -0.4% | -6.2% |
| Oct 20 | Goldman Sachs | Maintains | Buy → Buy | — | $13.77 | $13.81 | +0.3% | +0.9% | -1.4% | +7.6% | -1.2% | -0.4% |
| Oct 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $12.50 | $12.60 | +0.8% | +1.2% | +8.9% | -0.4% | +0.4% | +0.9% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | TETRAULT LYNN A.Dir | — | Sell | 5,307 | $11.10 | $59K | 86,115 | +7.23% | — |
| Jun 9, 2026 | TETRAULT LYNN A.Dir | — | Sell | 5,307 | $11.29 | $60K | 91,422 | -2.79% | +7.23% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 7,622,187 | $57M | New | Mar 2026 |
| 2 | Braidwell Lp | 4,632,801 | $54M | Added | Dec 2025 |
| 3 | Morgan Stanley | 4,252,098 | $50M | Reduced | Dec 2025 |
| 4 | First Trust Advisors Lp | 6,162,371 | $46M | New | Mar 2026 |
| 5 | Vanguard Capital Management Llc | 5,655,823 | $42M | New | Mar 2026 |
| 6 | D.e. Shaw & Co | 4,164,183 | $31M | Reduced | Mar 2026 |
| 7 | Schroder Investment Management Group | 3,568,578 | $26M | Reduced | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 3,054,198 | $23M | Added | Mar 2026 |
| 9 | Samlyn Capital, Llc | 2,557,349 | $19M | Added | Mar 2026 |
| 10 | Millennium Management | 2,222,757 | $16M | Reduced | Mar 2026 |
| 11 | Aberdeen Group Plc | 2,026,893 | $15M | Added | Mar 2026 |
| 12 | Northern Trust Corp | 1,580,827 | $12M | Added | Mar 2026 |
| 13 | Connor, Clark & Lunn Investment Management Ltd. | 877,949 | $10M | Added | Dec 2025 |
| 14 | Glenmede Trust Co Na | 1,297,183 | $10M | New | Mar 2026 |
| 15 | Segall Bryant & Hamill, Llc | 1,133,026 | $8M | New | Mar 2026 |
| 16 | Principal Financial Group Inc | 616,909 | $7M | Reduced | Dec 2025 |
| 17 | Bank Of New York Mellon Corp | 714,354 | $5M | Reduced | Mar 2026 |
| 18 | Jpmorgan Chase & Co | 605,663 | $4M | Added | Mar 2026 |
| 19 | Highmark Wealth Management Llc | 579,834 | $4M | Added | Mar 2026 |
| 20 | Invesco Ltd. | 562,465 | $4M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$285.2M
Enterprise Value
$530.2M
P/E (TTM)
-2.65x
Forward P/E
62.70x
PEG Ratio
-0.08x
P/B
0.34x
P/S
0.39x
P/FCF
-13.09x
EV/EBITDA
303.85x
Shares Out
25.6M
Financials (TTM)
Revenue
$727.3M
Net Income
-$108.0M
EBITDA
$1.7M
Free Cash Flow
-$21.8M
Op Cash Flow
$5.2M
EPS Basic
$-4.20
EPS Diluted
$-4.20
EPS Forward
$0.18
Gross Margin
38.9%
Op Margin
-9.1%
Net Margin
-14.8%
Balance Sheet
Total Assets
$1.36B
Total Liab.
$523.3M
Total Equity
$836.6M
Cash
$159.6M
LT Debt
$404.7M
Book Value/Sh
$32.65
Debt/Equity
0.56x
Current Ratio
4.26
Quick Ratio
3.94
Returns & Growth
ROE
-12.0%
ROA
-7.4%
ROIC
-5.1%
Rev Growth YoY
+10.1%
EPS Growth YoY
-35.5%
Price Returns
2W
+25.8%
1M
+13.6%
3M
+7.0%
6M
-13.1%
12M
+44.5%
Technicals
52W High
$13.22
52W Low
$4.84
50d MA
$9.32
200d MA
$10.00
RSI (14)
56.40
ATR (14)
$0.63
Beta
1.71
Avg Volume
2.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$19.00
High
$25.00
Low
$13.00
Median
$19.00
Data updated apr 26, 2026 2:39pm
· Source: financialmodelingprep.com